SAINT LAURENT, Quebec, Nov. 02, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced it has filed a new ...
A new generic oral anticoagulant in orodispersible film formulation has won regulatory support in Europe, potentially broadening access and ease of use for patients requiring anticoagulation across ...